To date,
reports Bloomberg, Roche has
lost 10 out of the 13 drug defect lawsuits brought over this medication since 2007, including a case in 2012 in which the
manufacturer was ordered to pay two plaintiffs $ 18 million and $ 25 million verdict to another plaintiff in 2010.